Enhancer-dependent transcriptional oscillations in mouse erythroleukemia cells.
By using recombinase-mediated cassette exchange, a method that allows integration of single copies of different constructs at the same predetermined chromosomal location, several expression cassettes have been integrated at a randomly chosen locus in the genome of mouse erythroleukemia cells. The cassettes studied contain the human beta-globin promoter fused to lacZ coding sequences either alone or linked to DNase I-hypersensitive site HS2, HS3, or HS234 (a large locus control region fragment containing HS2, HS3, and HS4) of the human beta-globin locus control region. Analysis of expression of these cassettes revealed mosaic expression patterns reminiscent of, but clearly different from, position effect variegation. Further investigations demonstrated that these mosaic expression patterns are caused by dynamic activation and inactivation of the transcription unit, resulting in oscillations of expression. These oscillations occur once in every few cell cycles at a rate specific for the enhancer present at the locus. DNase I sensitivity studies revealed that the chromatin is accessible and that DNase-hypersensitive sites were present whether or not the transcription unit is active, suggesting that the oscillations occur between transcriptionally competent and transcriptionally active chromatin conformations, rather than between open and closed chromatin conformations. Treatment of oscillating cells with trichostatin A eliminates the oscillations only after the cells have passed through late G1 or early S, suggesting that these oscillations might be caused by changes in histone acetylation patterns.
Feng
Y Q
YQ
Division of Hematology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Alami
R
R
Bouhassira
E E
EE
D000818:Animals; D003850:Deoxyribonuclease I; D004742:Enhancer Elements, Genetic; D016193:G1 Phase; D005786:Gene Expression Regulation; D005914:Globins / Q000235:genetics*; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology; D004915:Leukemia, Erythroblastic, Acute; D051379:Mice; D009030:Mosaicism; D016196:S Phase; D014158:Transcription, Genetic; D015533:Transcriptional Activation; D014407:Tumor Cells, Cultured
D006877:Hydroxamic Acids; C012589:trichostatin A; D005914:Globins; D003850:Deoxyribonuclease I